Exelixis
EXEL
#1820
Rank
A$16.53 B
Marketcap
A$61.43
Share price
-1.23%
Change (1 day)
11.66%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: A$16.53 Billion

As of December 2025 Exelixis has a market cap of A$16.53 Billion. This makes Exelixis the world's 1820th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025A$16.53 B6.53%
2024A$15.52 B41.76%
2023A$10.95 B44.02%
2022A$7.60 B-4.7%
2021A$7.97 B-1.48%
2020A$8.09 B5.9%
2019A$7.64 B-8.67%
2018A$8.37 B-27.32%
2017A$11.52 B92.1%
2016A$5.99 B239.79%
2015A$1.76 B412.03%
2014A$0.34 B-72.82%
2013A$1.26 B56.99%
2012A$0.80 B29.04%
2011A$0.62 B-29.13%
2010A$0.88 B-0.23%
2009A$0.88 B17.84%
2008A$0.75 B-27.33%
2007A$1.03 B-5.66%
2006A$1.09 B2.06%
2005A$1.07 B16.63%
2004A$0.92 B36.15%
2003A$0.67 B-19.81%
2002A$0.84 B-53.88%
2001A$1.82 B49.59%
2000A$1.22 B

End of Day market cap according to different sources

On Dec 13th, 2025 the market cap of Exelixis was reported to be:

A$16.47 Billion
by Nasdaq info icon info icon
A$16.53 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
A$148.00 B 794.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
A$178.55 B 979.73%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$376.46 B 2,176.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$160.32 B 869.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$257.10 B 1,454.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$766.01 B 4,532.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$220.86 B 1,235.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
A$22.53 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
A$0.78 B-95.26%๐Ÿ‡บ๐Ÿ‡ธ USA